Jorma Ilonen Selected Research

casein hydrolysate

1/2018	Effect of Hydrolyzed Infant Formula vs Conventional Formula on Risk of Type 1 Diabetes: The TRIGR Randomized Clinical Trial.
10/2017	Avoidance of Cow's Milk-Based Formula for At-Risk Infants Does Not Reduce Development of Celiac Disease: A Randomized Controlled Trial.
11/2010	Dietary intervention in infancy and later signs of beta-cell autoimmunity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jorma Ilonen Research Topics

Disease

168	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022 - 01/2002
23	Infections 11/2022 - 01/2003
17	Celiac Disease (Celiac Sprue) 12/2020 - 08/2002
11	Disease Susceptibility (Diathesis) 01/2022 - 02/2004
10	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 05/2002
9	Hypersensitivity (Allergy) 01/2022 - 01/2010
9	Genetic Predisposition to Disease (Genetic Predisposition) 12/2020 - 03/2003
8	Asthma (Bronchial Asthma) 01/2022 - 12/2011
7	Enterovirus Infections 01/2020 - 01/2003
7	Virus Diseases (Viral Diseases) 01/2020 - 08/2006
6	Insulinoma 01/2021 - 01/2007
5	Milk Hypersensitivity (Milk Allergy) 11/2021 - 08/2014
4	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2022 - 11/2011
3	Disease Progression 01/2019 - 01/2015
2	Allergic Rhinitis 11/2021 - 01/2013
2	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2009
2	Birth Weight (Birth Weights) 01/2021 - 07/2012
2	Adenoviridae Infections (Adenovirus Infections) 01/2020 - 08/2006
2	Inflammation (Inflammations) 01/2020 - 04/2013
2	Glucose Intolerance 01/2017 - 08/2015
2	Bacterial Infections (Bacterial Infection) 01/2015 - 06/2011
2	Insulin Resistance 10/2013 - 01/2009
2	Otitis Media 11/2011 - 07/2008
2	Multiple Sclerosis 06/2011 - 03/2003
2	Rheumatoid Arthritis 06/2007 - 04/2002
1	Frailty 12/2021

Drug/Important Bio-Agent (IBA)

95	AutoantibodiesIBA 01/2022 - 01/2002
41	Insulin (Novolin)FDA Link 01/2022 - 05/2002
33	AntibodiesIBA 01/2022 - 06/2003
30	1,3-di(4-imidazolinophenoxyl)propaneIBA 01/2022 - 01/2003
19	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022 - 09/2006
19	Proteins (Proteins, Gene)FDA Link 10/2017 - 05/2002
15	AntigensIBA 11/2020 - 08/2002
14	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 01/2022 - 06/2003
13	Immunoglobulin G (IgG)IBA 01/2020 - 02/2004
11	HLA-DR Antigens (HLA-DR)IBA 11/2020 - 09/2003
11	HLA-DQB1 antigen (HLA DQB1)IBA 01/2019 - 03/2002
7	Fatty Acids (Saturated Fatty Acids)IBA 11/2021 - 12/2011
7	Immunoglobulin E (IgE)IBA 11/2021 - 01/2010
7	HLA-DQ Antigens (HLA-DQ)IBA 01/2021 - 01/2005
7	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 02/2013
6	CytokinesIBA 01/2022 - 11/2006
6	Immunoglobulin A (IgA)IBA 01/2020 - 09/2007
6	Protein Glutamine gamma Glutamyltransferase 2IBA 01/2020 - 06/2003
6	Biomarkers (Surrogate Marker)IBA 01/2019 - 02/2013
5	Zinc Transporter 8IBA 01/2021 - 11/2010
5	Glutens (Glutelin)IBA 01/2020 - 08/2006
5	RNA (Ribonucleic Acid)IBA 01/2018 - 11/2007
5	GliadinIBA 01/2016 - 08/2006
5	Peptides (Polypeptides)IBA 05/2015 - 02/2004
5	AutoantigensIBA 01/2012 - 05/2002
4	Dietary ProteinsIBA 10/2019 - 11/2010
4	Vitamin D FDA LinkGeneric 01/2019 - 01/2016
4	VaccinesIBA 01/2018 - 11/2011
4	AllergensIBA 05/2011 - 01/2010
4	EpitopesIBA 07/2008 - 04/2002
3	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 11/2021 - 12/2011
3	ProinsulinIBA 01/2020 - 11/2005
3	25-hydroxyvitamin DIBA 01/2019 - 11/2014
3	LipidsIBA 01/2019 - 12/2008
3	EnzymesIBA 01/2019 - 05/2006
3	TransglutaminasesIBA 01/2018 - 10/2005
3	casein hydrolysateIBA 01/2018 - 11/2010
3	Interleukin-17 (Interleukin 17)IBA 10/2016 - 08/2010
3	Immunoglobulin M (IgM)IBA 04/2014 - 06/2012
3	Neutralizing AntibodiesIBA 07/2008 - 02/2004
3	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2004 - 03/2003
2	alpha-Linolenic Acid (Linolenic Acid)IBA 11/2021 - 12/2011
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2021 - 01/2007
2	AntioxidantsIBA 01/2021 - 08/2008
2	Tyrosine (L-Tyrosine)FDA Link 01/2021 - 01/2007
2	HLA-DQA1 antigen (HLA DQA1)IBA 12/2020 - 03/2015
2	Phospholipids (Phosphatides)FDA LinkGeneric 10/2020 - 09/2013
2	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2020 - 04/2013
2	Amino Acids FDA Link 12/2019 - 12/2008
2	hydroxide ionIBA 01/2019 - 11/2014
2	Chemokine ReceptorsIBA 01/2019 - 06/2007
2	Caseins (Casein)FDA Link 01/2018 - 06/2014
2	Genetic Markers (Genetic Marker)IBA 01/2017 - 01/2013
2	Blood Glucose (Blood Sugar)IBA 10/2016 - 05/2015
2	Complement System Proteins (Complement)IBA 01/2016 - 05/2015
2	C-PeptideIBA 01/2016 - 11/2006
2	HLA-DRB1 Chains (HLA DRB1)IBA 03/2015 - 04/2002
2	Palmitic Acid (Hexadecanoic Acid)IBA 03/2014 - 12/2011
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2008 - 09/2003
2	SelectinsIBA 05/2006 - 01/2004
2	Messenger RNA (mRNA)IBA 04/2006 - 09/2003
2	Protein Tyrosine PhosphatasesIBA 03/2005 - 06/2003
1	DNA (Deoxyribonucleic Acid)IBA 11/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022
1	GAD65 (96-585)IBA 01/2022
1	Epidermal Growth Factor (EGF)IBA 01/2022
1	Trans Fatty AcidsIBA 11/2021
1	Linoleic Acid (Linoleate)IBA 11/2021
1	Biological ProductsIBA 11/2021
1	IronIBA 03/2021
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 03/2021

Therapy/Procedure

3	Therapeutics 01/2018 - 04/2002